STOCK TITAN

Planned PASG (NASDAQ: PASG) Form 144 common share sale disclosed

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A shareholder of PASG has filed a Form 144 notice to potentially sell 4,076 shares of common stock through broker Maxim Group on NASDAQ. The shares to be sold have an aggregate market value of 75,120.00, compared with 3,178,710 shares of the same class reported as outstanding, and the filer lists an approximate sale date of 01/09/2026.

The securities were originally acquired as restricted stock from the issuer on 01/15/2025, with 10,000 shares obtained as compensation and a stated payment date of 01/09/2026. By signing the notice, the selling holder represents that they are not aware of any material adverse, nonpublic information about the issuer’s current or prospective operations.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the PASG Form 144 filing disclose?

The Form 144 filing discloses that a holder of PASG common stock plans the potential sale of 4,076 shares through Maxim Group on NASDAQ, with an approximate sale date of 01/09/2026 and an aggregate market value of 75,120.00.

How many PASG shares are planned to be sold under this Form 144?

The notice states that 4,076 shares of PASG common stock are to be sold, with an aggregate market value of 75,120.00 and an approximate sale date of 01/09/2026.

How many PASG shares are outstanding compared with the shares to be sold?

The filing reports 3,178,710 shares of the same class of PASG common stock outstanding, compared with the 4,076 shares covered by this planned sale.

How and when were the PASG shares in this Form 144 originally acquired?

The shares were acquired as restricted stock from the issuer on 01/15/2025. The form shows that 10,000 shares were acquired as compensation, with a listed date of payment of 01/09/2026.

Which broker and exchange are involved in this PASG Form 144 sale?

The filing lists Maxim Group, located at 300 Park Ave, 16th Floor, New York, NY 10022, as the broker, and names NASDAQ as the securities exchange for the planned sale of PASG common stock.

What representation does the selling holder make in the PASG Form 144?

By signing the notice, the person for whose account the PASG securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.
Passage Bio, Inc.

NASDAQ:PASG

PASG Rankings

PASG Latest News

PASG Latest SEC Filings

PASG Stock Data

45.39M
3.11M
0.21%
54.5%
2.63%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
PHILADELPHIA